Telomir Pharmaceuticals, Inc. Quarterly Interest Expense in USD for Q1 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of the cost of borrowed funds accounted for as interest expense.
Summary: Telomir Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate for Q1 2024.
Telomir Pharmaceuticals, Inc. Interest Expense for the quarter ending March 31, 2024 was $4.34M.

Interest Expense, Quarterly (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2024		$4.34M			Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-13

* An asterisk sign (*) next to the value indicates that the value is likely invalid.